Regiocit 5.29 g (Sodium Citrate SOLUTION) 5.29 G

Regiocit 5.29 G is a sodium citrate solution used for anticoagulation during extracorporeal procedures. This pharmaceutical is manufactured by Vantive ULC in Canada.

Strength

5.29 G

Manufacturer / TM Owner

VANTIVE ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Regiocit 5.29 G is primarily used for anticoagulation in extracorporeal procedures. Sodium citrate, the active ingredient, helps prevent blood clotting during processes like dialysis or blood transfusion. This solution is designed to maintain blood flow and ensure the safety of these medical procedures.

Side Effects

When used as directed, Regiocit 5.29 G helps to inhibit blood clotting, allowing for smooth extracorporeal procedures. The solution works by binding calcium ions, which are essential for the clotting process. This can help maintain the integrity of blood components during procedures.

Precautions & Warnings

Regiocit 5.29 G should be handled with care and stored according to manufacturer guidelines. It is important to follow proper administration protocols to avoid complications. Always consult healthcare professionals for specific handling and safety instructions.

Avoid Interactions

Regiocit 5.29 G may interact with other medications or substances that affect blood clotting. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Always follow medical advice regarding the use of this solution.

Frequently Asked Questions

Regiocit 5.29 G is used for anticoagulation during extracorporeal procedures, such as dialysis or blood transfusion.

Sodium citrate works by binding calcium ions, which are necessary for blood clotting, thereby preventing clots from forming.

The common effects include inhibition of blood clotting, allowing for smooth extracorporeal procedures.

It is important to consult healthcare providers about potential interactions with other medications.

Regiocit 5.29 G should be stored according to the manufacturer's guidelines to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.